Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients
NCT02696525 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 145
Last updated 2018-05-21
Summary
Conduct a prospective study to confirm blood and urine ctDNA detection value in non-small-cell lung cancer patients.
Conditions
- Carcinoma
- Non-small-cell Lung Cancer
- Lung Neoplasms
Sponsors & Collaborators
-
San Valley Biotechnology Incorporated
collaborator UNKNOWN -
Peking University People's Hospital
lead OTHER
Principal Investigators
-
Jun Wang, M.D. · Peking University People's Hospital
-
Yilong Wu, M.D. · Guang Dong General Hospital
-
Lin Xu, M.D. · Jiang Su Cancer Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-31
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- China
Study Locations
More Related Trials
-
Dynamic Monitoring Circulating Tumor DNA in Surgical Patients With Lung Cancer
NCT03317080 ·Status: UNKNOWN
-
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
NCT02715102 ·Status: TERMINATED
-
Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA
NCT02833467 ·Status: UNKNOWN
-
Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients
NCT03664843 ·Status: UNKNOWN
-
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
NCT05066945 ·Status: NOT_YET_RECRUITING
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS
NCT03465241 ·Status: COMPLETED
-
Multiplex Analysis of Circulating Tumor DNA
NCT03301961 ·Status: UNKNOWN
-
Changes in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung Cancer
NCT03746262 ·Status: COMPLETED
-
Evaluation ctDNA in Patients of Non-Small-Cell Lung Cancer Following Resection
NCT04238130 ·Status: COMPLETED
-
ctDNA as a Biomarker for Treatment in Advanced NSCLC
NCT05486988 ·Status: UNKNOWN
-
Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).
NCT03634826 ·Status: UNKNOWN
-
Preoperative and Postoperative ctDNA Comparison in Early Stage Lung Cancer
NCT03805256 ·Status: UNKNOWN
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma
NCT06477211 ·Status: COMPLETED
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Using ctDNA to Determine Therapies for Lung Cancer
NCT04966663 ·Status: RECRUITING ·Phase: PHASE2
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
Cancer Panel From Blood of Lung Cancer Patients
NCT03235765 ·Status: UNKNOWN
-
Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection
NCT05254782 ·Status: RECRUITING
-
Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
NCT02804100 ·Status: UNKNOWN
-
Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA
NCT03926260 ·Status: COMPLETED ·Phase: NA
-
The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer
NCT02380196 ·Status: COMPLETED
-
Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma
NCT03090815 ·Status: UNKNOWN
-
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
NCT00471978 ·Status: RECRUITING
-
CirculAting Tumor DNA in Patients DIagnosed With Lung Metastasis From Colorectal Cancer: candiDate Selection for Local AblaTive thErapy
NCT04704960 ·Status: UNKNOWN